Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
12 Agosto 2024 - 11:03AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SEC File Number 000-49819
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check one):
o Form 10-K o
Form 20-F o Form
11-K x Form 10-Q o
Form 10-D o Form
N-CEN o N-CSR
For Period Ended: June 30, 2024
o Transition
Report on Form 10-K
o Transition
Report on Form 20-F
o Transition
Report on Form 11-K
o Transition
Report on Form 10-Q
For the Transition Period Ended: _______________
Read Instruction (on back page) Before Preparing
Form. Please Print or Type.
Nothing in this form shall be construed to imply
that the Commission has verified any information contained herein. |
If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates: |
|
PART I - REGISTRANT INFORMATION
Full Name of Registrant |
BioRegenx, Inc. |
Former Name if Applicable: |
|
Address of Principal Executive Office (Street and Number): |
7407 Ziegler Road |
City, State and Zip Code: |
Chattanooga, TN 37421 |
PART II - RULES 12b-25(b) AND (c)
If the subject
report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following
should be completed. (Check box if appropriate) x
|
(a) |
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
|
(b) |
The subject annual report, semi-annual report, transition report on Forms 10-K, 20-F, 11-K, Form N-SAR, or portion thereof, will be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and |
|
(c) |
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
PART III - NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 20-F,
11-K, 10-Q, N-CEN, N-SAR, or the transition report portion thereof, could not be filed within the prescribed time period.
Due to the recent change in auditors, the registrant is unable to complete
its audit and preparation of its Form 10-Q for the period ended June 30, 2024 in a timely manner because of unanticipated delays.
PART IV - OTHER INFORMATION
(1) |
Name and telephone number of person to contact in regard to this notification: |
J.M. Walker & Associates Attorneys
at Law |
|
(303) 850-7637 |
(Name) |
|
(Area Code) (Telephone number) |
(2) |
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months (or for such shorter) period that the registrant was required to file such reports) been filed? If answer is no, identify report(s): xYes oNo |
(3) |
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof: oYes xNo |
If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
BioRegenx, Inc. has caused this notification to be signed on its behalf
by the undersigned hereunto duly authorized.
Date: |
August 12, 2024 |
|
By: |
/s/ William Resides |
|
|
|
|
|
Chief Executive Officer |
|
Findit (PK) (USOTC:FDIT)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
Findit (PK) (USOTC:FDIT)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024